A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical cancer

Not Applicable

• Conditions: advanced and recurrent cervical cancer

• Registration Number: JPRN-UMIN000003999
• Lead Sponsor: Saitama medical university international medical center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-04
• Study Completion: 2015-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 18

Inclusion Criteria

Not provided

Exclusion Criteria

severe heart disease patients treated with systemic corticosteroids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
safety